Figure 11From: What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDsAdditional risk of dying from an upper gastrointestinal bleed or cardiovascular event with celecoxib. For representational purposes an additional risk of 1 in about 100,000 was assumed where there was no numerically increased risk, here for either risk. GI, gastrointestinal. GI, gastrointestinal.Back to article page